Sandra Misale

Also affiliated with University of Baltimore

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer”.

EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0187

N/A

0DataRank · unranked

493 citations

Rona Yaeger, Pamela Arcella, Carlotta Cancelliere, Simona Lamba, Annalisa Lorenzato +24 more

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0215

N/A

0DataRank · unranked

293 citations

Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai +44 more

TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0571

N/A

0DataRank · unranked

70 citations

Ji Eun Lee, Srinivasaraghavan Kannan, Alison M. Schram, Helen Won, Sophie Shifman +29 more

Anatomic position determines oncogenic specificity in melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.11.14.383083

N/A

0DataRank · unranked

13 citations

Miranda V. Hunter, Nelly M. Cruz, Arianna Baggiolini, Mohita Tagore, Yilun Ma +35 more

Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

Cancer Discovery(2022)10.1158/2159-8290.cd-22-0405

N/A

0DataRank · unranked

140 citations

Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco, Esther Kaplun +29 more

Anatomic position determines oncogenic specificity in melanoma

Nature(2022)10.1038/s41586-022-04584-6

N/A

0DataRank · unranked

99 citations

Miranda V. Hunter, Nelly M. Cruz, Arianna Baggiolini, Mohita Tagore, Yilun Ma +35 more

Molecular characterization of acquired resistance to KRAS G12C inhibition in gastrointestinal cancers

Research Square(2022)10.21203/rs.3.rs-1236956/v1

N/A

0DataRank · unranked

2 citations

Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco +23 more

Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3135

N/A

0DataRank · unranked

0 citations

Yonina R. Murciano‐Goroff, Justin Jee, Maria E. Arcila, Darren J. Buonocore, Jianjiong Gao +15 more

Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers

The Oncologist(2023)10.1093/oncolo/oyad247

N/A

0DataRank · unranked

13 citations

Ann Maria, Nicolas Toumbacaris, HuiYong Zhao, Katherine E. Kargus, Morgan Bryant +11 more

EGFR-directed antibodies promote HER2 ADC internalization and efficacy

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101792

N/A

0DataRank · unranked

31 citations

Flavia Michelini, Hong Shao, Celine Yeh, Joshua Z. Drago, Dazhi Liu +12 more

Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101818

N/A

0DataRank · unranked

4 citations

Dinesh Kumar, Tessa Seale, Santiago Garcia Borrego, Esther Kaplun, Ilinca Aricescu +17 more

Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations

Cancer Discovery(2025)10.1158/2159-8290.cd-24-0614

N/A

0DataRank · unranked

12 citations

Dinesh Kumar, Santiago Garcia Borrego, Tessa Seale, Giulia Maddalena, Riccardo Mezzadra +19 more